Bank of America Corp DE Increases Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Bank of America Corp DE lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 27.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,474 shares of the medical instruments supplier's stock after buying an additional 14,863 shares during the quarter. Bank of America Corp DE owned approximately 1.26% of Mesa Laboratories worth $9,030,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Ameriprise Financial Inc. increased its stake in Mesa Laboratories by 191.8% in the 4th quarter. Ameriprise Financial Inc. now owns 151,862 shares of the medical instruments supplier's stock worth $20,026,000 after buying an additional 99,819 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Mesa Laboratories by 1,390.4% in the fourth quarter. Jane Street Group LLC now owns 34,399 shares of the medical instruments supplier's stock worth $4,536,000 after acquiring an additional 32,091 shares during the period. Northern Trust Corp grew its position in shares of Mesa Laboratories by 2.0% during the fourth quarter. Northern Trust Corp now owns 93,789 shares of the medical instruments supplier's stock worth $12,368,000 after purchasing an additional 1,825 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Mesa Laboratories by 12.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,469 shares of the medical instruments supplier's stock valued at $458,000 after purchasing an additional 390 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Mesa Laboratories by 72.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,328 shares of the medical instruments supplier's stock valued at $175,000 after purchasing an additional 560 shares during the period. Hedge funds and other institutional investors own 90.60% of the company's stock.

Insiders Place Their Bets

In other news, CEO Gary M. Owens sold 21,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares in the company, valued at approximately $5,369,887.67. This represents a 32.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 4.40% of the company's stock.

Mesa Laboratories Price Performance

MLAB stock traded up $1.57 during midday trading on Thursday, hitting $104.64. The company's stock had a trading volume of 52,455 shares, compared to its average volume of 40,208. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $155.12. The company has a 50 day moving average of $115.72 and a two-hundred day moving average of $126.11. The firm has a market capitalization of $568.61 million, a price-to-earnings ratio of -2.26 and a beta of 0.97.

Mesa Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories's payout ratio is currently -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.